Print（PDF/160KB） Mar. 01, 2017 Corporate

Sumitomo Dainippon Pharma announces Organizational Realignment and Changes in Executive Officers and Other Key Positions

Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; President: Masayo Tada) today announced that the following organizational realignment and Changes in the posts assumed by Executive Officers and other key positions, effective April 1, 2017:

Ⅰ. Organizational Realignment (effective April 1, 2017)

Corporate Departments

Corporate IT Management is renamed to IT Management & Digital Transformation.^＊

＊Amid the accelerated progress of digital technology, we intend to review the department's mission and change its name as part of our bold efforts to promote digital innovation (operational and business model reforms through strategic use of digital technology), digital healthcare, and big data utilization within the Sumitomo Dainippon Pharma Group.

Ⅱ. Changes in Executive Officers (effective April 1, 2017)

Position as of April 1, 2017	Current position	Name
Representative Director, Executive Vice President Global Corporate Planning; External Affairs; Corporate Secretariat & Industry Affairs; Personnel; Finance & Accounting	Member, Board of Directors, Executive Vice President External Affairs; Corporate Secretariat & Industry Affairs; Finance & Accounting; Drug Development Division; Special Assignments	Hiroshi Nomura
Member, Board of Directors, Executive Officer Regenerative & Cellular Medicine Office; Regenerative & Cellular Medicine Kobe Center; Drug Research Division	Member, Board of Directors, Executive Officer Senior Director, Global Corporate Planning; Regenerative & Cellular Medicine Office; Regenerative & Cellular Medicine Kobe Center	Toru Kimura
Senior Executive Officer Executive Director, Manufacturing Division; Technology Research & Development Division	Senior Executive Officer Executive Director, Manufacturing Division; Executive Director, Technology Research & Development Division	Yoshiharu Ikeda
Senior Executive Officer Boston Biomedical, Inc.; Global Oncology Office; Oncology Clinical Development Unit; Oncology Strategy Unit; Head of Global Oncology Office	Senior Executive Officer Boston Biomedical Pharma, Inc.; Global Oncology Office; Oncology Clinical Development Unit; Oncology Strategy Unit; Head of Global Oncology Office	Kazuo Koshiya
Executive Officer Executive Director, Corporate Regulatory Compliance & Quality Assurance Division; Regulatory Affairs; Medical Information; Medical Affairs; Drug Development Division	Executive Officer Executive Director, Drug Development Division	Nobuyuki Hara
Executive Officer Senior Director, Global Corporate Planning; Legal Affairs; Intellectual Property; IT Management & Digital Transformation	Executive Officer Global Business Development; Legal Affairs; Intellectual Property; Corporate IT Management; International Business Management; Head of Global Business Development for Sumitomo Dainippon Pharma Group	Hiroyuki Baba
Executive Officer Corporate Governance (External communications); Personnel (Diversification)	Senior Communication Officer	Atsuko Higuchi
Executive Officer Senior Director, Global Business Development; International Business Management	Senior Director, Global Business Development	Shigeyuki Nishinaka

"Changes of Representative Directors and Executive Officers effective on March 31 and April 1, 2017" was disclosed on February 24, 2017.

Ⅲ. Changes in Personnel (effective April 1, 2017)

Corporate Departments

Position as of April 1, 2017	Current position	Name
Senior Strategic Officer - International business	Senior Advisor, Global Corporate Planning	Shinichiro Katayanagi
Senior Oncology Financial Officer	-	Katsuyuki Kaitonaka
Senior Director, External Affairs	Industrial Policy Officer, External Affairs	Tomokazu Nagano
Senior Director, IT Management & Digital Transformation	Senior Director, Corporate IT Management	Kyoichi Yokota

Corporate Regulatory Compliance & Quality Assurance (Division)

Position as of April 1, 2017	Current position	Name
Senior Director, Quality Management	Deputy Senior Director, Quality Assurance, Oita Plant	Yasuhiro Kanzaki
Senior Director, Pharmacovigilance	Director, Safety Evaluation Group, Pharmacovigilance	Koichi Kino
Senior Director, Clinical & Research Quality Assurance	Senior Director, Pharmacovigilance	Keiko Tsuchiya

Drug Development (Division)

Position as of April 1, 2017	Current position	Name
Executive Director, Drug Development Division	-	Koichi Kozuki
Senior Director, Data Science	Director, Biostatistics Group, Data Science	Satoru Tsuchiya

Technology Research & Development (Division)

Position as of April 1, 2017	Current position	Name
Executive Director, Technology Research & Development Division	Deputy Executive Director, Technology Research & Development Division; Senior Director, Technology Research & Development Management	Kazuhiko Takahashi
Senior Director, Technology Research & Development Management	Senior Director, Quality Management	Yuko Morioka

Manufacturing (Division)

Position as of April 1, 2017	Current position	Name
Deputy Executive Director, Manufacturing Division; Senior Director, Suzuka Plant	Deputy Executive Director, Manufacturing Division; Senior Director, Suzuka Plant; Deputy Senior Director, Administration	Hotaka Hashimoto
Senior Director, Engineering	Director, Production Control & Logistics Management Group, Manufacturing Management	Ken Imamura
Deputy Senior Director, Administration, Suzuka Plant	Deputy Senior Director, Manufacturing, Suzuka Plant; Director, Drug Substance Section	Noriko Amano
Deputy Senior Director, Manufacturing, Suzuka Plant	Director, CTM Manufacturing Group, Formulation Research & Development Laboratories	Hideo Kurita
Deputy Senior Director, Quality Assurance, Oita Plant	Director, Quality Assurance Group, Quality Assurance, Suzuka Plant	Toyohiro Nishikawa